Clinical Trials Logo

Filter by:
NCT ID: NCT04296526 Not yet recruiting - Sedentary Behavior Clinical Trials

Two-phase Transteoretic Model Research for Participation in Physical Activity

Start date: April 2021
Phase: N/A
Study type: Interventional

The purpose of the first phase of this study is to determine the physical activity (PA) barriers and motivational factors of university students and their body awareness using the transteoretic model (TTM). The aim of the second phase of the study is to evaluate the effectiveness of interventions aimed at eliminating barriers determined in students who are in the "precontemplation", "contemplation" and "preparation" stages according to TTM. Also it will be examined the effects of these interventions on PA level.

NCT ID: NCT04416724 Not yet recruiting - Clinical trials for Pseudoexfoliation Glaucoma

Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma

CANPEX1
Start date: April 2021
Phase: N/A
Study type: Interventional

The Canadian Pseudoexfoliation Glaucoma Study 1 is a randomized clinical trial that aims to compare two initial treatment options - Selective Laser Trabeculoplasty (SLT) and Phacoemulsification (PHACO) - in newly diagnosed patients with pseudoexfoliation and need to lower the intraocular pressure. Patients with pseudoexfoliation and a recent decision to lower the intraocular pressure, who also have early asymptomatic lens opacification will be recruited and randomized to receive either SLT or PHACO. Patients will be followed for 2 years according to a target IOP protocol based on the Canadian Ophthalmological Society Glaucoma guidelines. Patients who do not achieve the target IOP with the initial randomization procedure will receive IOP lowering medications. The main outcome of interest will be the proportion of subjects who need IOP lowering medications after 2 years. Secondary outcomes include IOP reduction, time to need medications, patient reported outcomes in terms of visual function, and occurrence of adverse effects. To obtain longer follow-up information beyond two years, a chart review will be done 5 and 10 years after randomization.

NCT ID: NCT04479527 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma

Start date: April 2021
Phase: Phase 2
Study type: Interventional

This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1 antibody camrelizumab and apatinib mesylas in the treatment of patients with advanced liver cancer, to evaluate the effectiveness and safety of the combined treatment for clinical liver cancer treatment.It will provide new evidence-based medical evidence.This study is a prospective, open, single center, exploratory clinical study and the sample size is 56.Main research purpose:To evaluate the effectiveness of cTACE or DEB-TACE + FOLFOX regimen HAIC combined with camrelizumab and apatinib mesylas in the treatment of advanced hepatocellular carcinoma.Secondary research purpose:To evaluate the safety of cTACE or DEB-TACE + FOLFOX regimen HAIC combined with camrelizumab and apatinib mesylas in the treatment of advanced hepatocellular carcinoma.

NCT ID: NCT04490967 Not yet recruiting - Acne Vulgaris Clinical Trials

Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris

Start date: April 2021
Phase: Phase 4
Study type: Interventional

Acne vulgaris is a disease of the pilosebaceous unit that causes noninflammatory lesions (open and closed comedones), inflammatory lesions (papules, pustules, and nodules), and varying degrees of scarring. Acne vulgaris is an extremely common condition with a lifetime prevalence of approximately 85% and occurs mostly during adolescence. Acne vulgaris leads to significant morbidity that is associated with residual scarring and psychological disturbances such as poor self-image, depression, and anxiety, which leads to a negative impact on quality of life. The treatment of acne vulgaris is challenging and often chronic, with high rates of failure and numerous choices. Frequent evaluations (i.e., every 8-12 weeks) are important to enable appropriate monitoring, manage adverse effects, and evaluate for medication compliance. Topical therapies are considered one of the mainstay treatments for patients with mild-to-moderate acne.

NCT ID: NCT04548453 Not yet recruiting - Pregnancy Related Clinical Trials

Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions

uSI-ranges
Start date: April 2021
Phase: Early Phase 1
Study type: Interventional

Patients receiving oxytocin for induction or augmentation of labor will be studied with uterine EMG. The results of the EMG will be converted to an oxytocin-associated uterine stimulation index (uSI), which is intended to guide decisions for changing the dose of oxytocin. An expert panel will review the results of the oxytocin dosing actions, then assigned optimized actions throughout the labor. The uSI will be correlated with the optimal dosing actions.

NCT ID: NCT04575376 Not yet recruiting - Syncope Clinical Trials

Clinical Audit on Evaluation of Patient With Syncope at Asssiut University Children Hospital

Start date: April 2021
Phase:
Study type: Observational

Evaluation of commitment of resident physician to the guidelines as regard management of cases of syncope at Assiut University Children Hospital and correction of the defect that will be discovered.

NCT ID: NCT04667806 Not yet recruiting - Clinical trials for Lung Transplantation

Health Related Quality of Life in Lung Transplantation in Strasbourg

Start date: April 2021
Phase:
Study type: Observational

The aim of this study is to study the quality of life in lung transplant patients. The cohort includes all of the surviving and transplanted patients at the New Civil Hospital in Strasbourg between 2008 and 2018. The main objective is to assess the quality of life of this cohort by two questionnaires which are the SF36 (generic score) and the saint Georges's questionnaire (specific score). The secondary objectives are the measurement of survival after lung transplantation, the comparison of the quality of life of these patients with that of the general population by the SF36 questionnaire, the search for perioperative factors influencing the quality of life and finally the search for an association between quality of life and socio-professional life.

NCT ID: NCT04705090 Not yet recruiting - PTCL Clinical Trials

A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Start date: April 2021
Phase: Phase 2
Study type: Interventional

A single-arm, open, multicenter study to investigate the efficacy and safety of YY-20394, an oral small molecular inhibitor of PI3K-delta, in patients with relapsed or refractory peripheral T/NK cell lymphoma.

NCT ID: NCT04706312 Not yet recruiting - Clinical trials for Diminished Ovarian Response

Transplantation of hAMSCs for Woman With DOR

Start date: April 2021
Phase: Phase 1
Study type: Interventional

Patients with Diminished ovarian response (DOR)have a poor in vitro fertilization(IVF) outcome, and is considered one of most challenging tasks in artificial reproductive treatment (ART). Stem cell therapies are rapidly progressing fields and have shown promise in treatment of lots of disease, including aging and premature ovarian failure. The purpose of this study is to determine the safety and efficacy of intra vein injection of human Amniotic Mesenchymal Stem Cells(hAMSCs) in women suffered from infertility caused by DOR.

NCT ID: NCT04710953 Not yet recruiting - Clinical trials for High Altitude Pulmonary Edema

Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE

CPAP
Start date: April 2021
Phase: N/A
Study type: Interventional

High altitude pulmonary edema (HAPE) is mostly treated with supplemental oxygen, nifedipine 30mg twice a day, rest, limiting cold exposure and descent (simulated or actual) Gamow Bag provides simulated descent and buy time for actual descent. CPAP is claimed to be effective in many case reports to treat HAPE temporarily until actual descent is taken place. This study aims to evaluate the role of CPAP in treating HAPE at those high altitude stations where Gamow bag is not available and immediate descent is not possible.